MATINAS BIOPHARMA HLDGS INC's ticker is MTNB and the CUSIP is 576810105. A total of 51 filers reported holding MATINAS BIOPHARMA HLDGS INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $3 | -99.4% | 6 | -99.4% | 0.00% | – |
| Q4 2022 | $466 | -53.4% | 931 | -43.7% | 0.00% | – |
| Q3 2022 | $1,000 | -66.7% | 1,655 | -54.5% | 0.00% | – |
| Q2 2022 | $3,000 | 0.0% | 3,638 | 0.0% | 0.00% | – |
| Q1 2022 | $3,000 | -98.0% | 3,638 | -97.5% | 0.00% | – |
| Q4 2021 | $148,000 | +7300.0% | 146,348 | +7927.9% | 0.00% | – |
| Q3 2021 | $2,000 | – | 1,823 | +2237.2% | 0.00% | – |
| Q2 2021 | $0 | -100.0% | 78 | -86.4% | 0.00% | – |
| Q1 2021 | $1,000 | -96.0% | 572 | -98.6% | 0.00% | – |
| Q1 2020 | $25,000 | -26.5% | 41,223 | +32.6% | 0.00% | – |
| Q1 2019 | $34,000 | +3300.0% | 31,089 | +3008.9% | 0.00% | – |
| Q3 2018 | $1,000 | -95.5% | 1,000 | -98.0% | 0.00% | – |
| Q2 2018 | $22,000 | +450.0% | 50,204 | +907.7% | 0.00% | – |
| Q1 2018 | $4,000 | -55.6% | 4,982 | -35.0% | 0.00% | – |
| Q4 2017 | $9,000 | +200.0% | 7,668 | +182.3% | 0.00% | – |
| Q3 2017 | $3,000 | – | 2,716 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| COURAGE CAPITAL MANAGEMENT LLC | 1,000,000 | $804,000 | 0.77% |
| Sargent Investment Group, LLC | 3,643,979 | $2,931,000 | 0.74% |
| Arkadios Wealth Advisors | 1,399,000 | $1,125,000 | 0.15% |
| Kingsbury Capital Investment Advisors LLC | 119,949 | $96,000 | 0.11% |
| JTC Employer Solutions Trustee Ltd | 775,000 | $632,000 | 0.07% |
| Platform Technology Partners | 142,410 | $115,000 | 0.06% |
| Main Street Financial Solutions, LLC | 400,826 | $322,000 | 0.05% |
| National Wealth Management Group, LLC | 32,100 | $25,821 | 0.02% |
| STALEY CAPITAL ADVISERS INC | 600,000 | $483,000 | 0.02% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 753,391 | $606,000 | 0.01% |